График акции Moleculin Biotech, Inc.
Расширенный график
Простой график
О компании Moleculin Biotech, Inc.
Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses. Its lead drug candidate is Annamycin, which is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066 that is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. подробнее| IPO date | 2016-06-02 |
|---|---|
| ISIN | US60855D2009 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.moleculin.com |
| Цена ао | 4.68 |
| Изменение цены за день: | -6.78% (1.77) |
|---|---|
| Изменение цены за неделю: | -1.2% (1.67) |
| Изменение цены за месяц: | -38.66% (2.69) |
| Изменение цены за 3 месяца: | -40% (2.75) |
| Изменение цены за полгода: | -53.78% (3.57) |
| Изменение цены за год: | +92.22% (0.8584) |
| Изменение цены за 3 года: | -20.67% (2.08) |
| Изменение цены за 5 лет: | +51.38% (1.09) |
| Изменение цены за 10 лет: | 0% (1.65) |
| Изменение цены с начала года: | -36.9% (2.615) |
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| Armistice Capital, LLC | 213829 | 9.6 |
| Vanguard Group Inc | 72009 | 3.23 |
| Geode Capital Management, LLC | 16445 | 0.74 |
| Blackrock Inc. | 12595 | 0.57 |
| Renaissance Technologies, LLC | 8640 | 0.39 |
| State Street Corporation | 4760 | 0.21 |
| Citadel Advisors Llc | 4310 | 0.19 |
| Northern Trust Corporation | 3573 | 0.16 |
| Atticus Wealth Management, LLC | 3333 | 0.15 |
| Schmidt (P.J.) Investment Management Inc. | 1933 | 0.09 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Mr. Walter V. Klemp | Co-Founder, Chairman, President & CEO | 894.54k | 1960 (65 лет) |
| Mr. Jonathan P. Foster CPA | Executive VP & CFO | 611.17k | 1964 (61 год) |
| Dr. Donald H. Picker Ph.D. | Chief Scientific Officer | 486.44k | 1946 (79 лет) |
| Dr. Waldemar Priebe Ph.D. | Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board | N/A | |
| Dr. John Paul Waymack M.D., Sc.D. | Senior Chief Medical Officer | N/A | 1952 (73 года) |
| Dr. Sandra L. Silberman M.D., Ph.D. | Chief Medical Officer of New Products | N/A | 1955 (70 лет) |
| Dr. Wolfram C. M. Dempke M.B.A., M.D., Ph.D. | European Chief Medical Officer | N/A |
Адрес: United States, Houston. TX, 5300 Memorial Drive - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.moleculin.com
Сайт: https://www.moleculin.com
